Published in J Biol Chem on November 24, 2000
Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol (2009) 5.43
Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc Natl Acad Sci U S A (2003) 3.28
Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell (2005) 3.26
Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci (2011) 2.59
Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res (2004) 2.33
Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J Biol Chem (2005) 1.96
Phospho-control of TGF-beta superfamily signaling. Cell Res (2009) 1.91
Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev (2001) 1.91
Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest (2008) 1.88
Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J Biol Chem (2003) 1.81
Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell (2003) 1.78
Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell (2001) 1.69
Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. EMBO J (2003) 1.68
Transforming growth factor-β and the hallmarks of cancer. Cell Signal (2010) 1.66
USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Nat Cell Biol (2012) 1.65
The regulatory utilization of genetic redundancy through responsive backup circuits. Proc Natl Acad Sci U S A (2006) 1.61
Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblasts. Respir Res (2004) 1.55
Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling. Oncogene (2011) 1.48
Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradation. EMBO Rep (2002) 1.42
The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. EMBO J (2004) 1.41
Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci U S A (2004) 1.41
A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20. Nat Med (2012) 1.40
Noncanonical TGF-β signaling during mammary tumorigenesis. J Mammary Gland Biol Neoplasia (2011) 1.38
p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity. J Biol Chem (2009) 1.37
Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice. Arthritis Rheum (2008) 1.31
Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation. J Biol Chem (2003) 1.31
Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Mol Cell Biol (2004) 1.30
Ablation of Smurf2 reveals an inhibition in TGF-β signalling through multiple mono-ubiquitination of Smad3. EMBO J (2011) 1.27
Smurf2 up-regulation activates telomere-dependent senescence. Genes Dev (2004) 1.23
Smad ubiquitination regulatory factor 2 promotes metastasis of breast cancer cells by enhancing migration and invasiveness. Cancer Res (2009) 1.22
Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development. Mol Cell Biol (2001) 1.20
17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. Am J Physiol Renal Physiol (2007) 1.17
Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage (2007) 1.16
Ubiquitin-dependent regulation of TGFbeta signaling in cancer. Neoplasia (2006) 1.14
ECM stiffness primes the TGFβ pathway to promote chondrocyte differentiation. Mol Biol Cell (2012) 1.14
CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. Mol Cell Biol (2004) 1.11
Critical regulation of TGFbeta signaling by Hsp90. Proc Natl Acad Sci U S A (2008) 1.10
Pin1 promotes transforming growth factor-beta-induced migration and invasion. J Biol Chem (2009) 1.10
Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation. J Biol Chem (2010) 1.09
Regulation of TGF-beta signalling by Fbxo11, the gene mutated in the Jeff otitis media mouse mutant. Pathogenetics (2009) 1.08
Regulation of TGF-beta signalling by protein phosphatases. Biochem J (2010) 1.08
Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition. Mol Cell Biol (2007) 1.07
USP11 augments TGFβ signalling by deubiquitylating ALK5. Open Biol (2012) 1.07
Roles of E3 ubiquitin ligases in cell adhesion and migration. Cell Adh Migr (2010) 1.07
Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis. Br J Cancer (2011) 1.06
Ubiquitylation of a melanosomal protein by HECT-E3 ligases serves as sorting signal for lysosomal degradation. Mol Biol Cell (2005) 1.05
Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II. J Biol Chem (2010) 1.05
Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication. Am J Physiol Renal Physiol (2008) 1.04
TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves. Cardiovasc Res (2013) 1.04
A negative feedback control of transforming growth factor-beta signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204. J Biol Chem (2009) 1.03
Smurf control in bone cells. J Cell Biochem (2010) 1.03
Retinoic acid regulates bone morphogenic protein signal duration by promoting the degradation of phosphorylated Smad1. Proc Natl Acad Sci U S A (2010) 1.02
A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs). BMC Cell Biol (2002) 1.02
Smad phosphoisoform signaling specificity: the right place at the right time. Carcinogenesis (2011) 1.02
Quantitative modeling and analysis of the transforming growth factor beta signaling pathway. Biophys J (2009) 1.00
Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor-beta signaling that affects neural crest formation. Mol Biol Cell (2009) 0.99
Smurf2 induces degradation of GSK-3beta and upregulates beta-catenin in chondrocytes: a potential mechanism for Smurf2-induced degeneration of articular cartilage. Exp Cell Res (2009) 0.99
Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype. J Biol Chem (2009) 0.99
Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol Cell Biol (2004) 0.98
To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications. Cell Signal (2008) 0.97
The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma. IUBMB Life (2009) 0.96
Smurf2-mediated ubiquitination and degradation of Id1 regulates p16 expression during senescence. Aging Cell (2011) 0.95
Aberrant hypertrophy in Smad3-deficient murine chondrocytes is rescued by restoring transforming growth factor beta-activated kinase 1/activating transcription factor 2 signaling: a potential clinical implication for osteoarthritis. Arthritis Rheum (2010) 0.95
Inhibition of Smurf2 translation by miR-322/503 modulates TGF-β/Smad2 signaling and intestinal epithelial homeostasis. Mol Biol Cell (2014) 0.95
Regulation of TGF-β signal transduction by mono- and deubiquitylation of Smads. FEBS Lett (2012) 0.95
Smurf2 regulates the senescence response and suppresses tumorigenesis in mice. Cancer Res (2012) 0.94
TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis. J Histochem Cytochem (2016) 0.93
Transforming growth factor-beta signaling and ubiquitinators in cancer. Endocr Relat Cancer (2008) 0.93
Overexpression of Smurf2 stimulates endochondral ossification through upregulation of beta-catenin. J Bone Miner Res (2008) 0.93
Fucoidan inhibition of lung cancer in vivo and in vitro : role of the Smurf2-dependent ubiquitin proteasome pathway in TGFβ receptor degradation. Oncotarget (2014) 0.93
Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets. Cancer Biol Ther (2010) 0.93
Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke. EMBO Mol Med (2013) 0.92
Selective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation. Sci Rep (2014) 0.91
Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System. J Biol Chem (2016) 0.91
Pivotal role of the C2 domain of the Smurf1 ubiquitin ligase in substrate selection. J Biol Chem (2011) 0.91
Leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction induces a novel genetic signature resulting in T-cells refractory to transforming growth factor-β signaling. J Biol Chem (2012) 0.91
The E3 ubiquitin ligase SMAD ubiquitination regulatory factor 2 negatively regulates Krüppel-like factor 5 protein. J Biol Chem (2011) 0.91
Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1. J Cell Biochem (2008) 0.90
Regulation of the transforming growth factor β pathway by reversible ubiquitylation. Open Biol (2012) 0.90
Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling. Oncogene (2008) 0.90
Key role for ubiquitin protein modification in TGFβ signal transduction. Ups J Med Sci (2012) 0.90
Ubiquitin-dependent degradation of Smad2 is increased in the glomeruli of rats with anti-thymocyte serum nephritis. Am J Pathol (2003) 0.90
Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines. J Cell Biochem (2003) 0.88
Smad signalling in the ovary. Reprod Biol Endocrinol (2006) 0.88
The regulation of TGF-β/SMAD signaling by protein deubiquitination. Protein Cell (2014) 0.88
Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer. Nat Commun (2015) 0.87
Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes. J Cell Biochem (2012) 0.87
RB1CC1 protein positively regulates transforming growth factor-beta signaling through the modulation of Arkadia E3 ubiquitin ligase activity. J Biol Chem (2011) 0.87
Ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells. J Biol Chem (2013) 0.85
The role of the ubiquitin-proteasome system in kidney diseases. Clin Exp Nephrol (2012) 0.85
TGF-β Induces Degradation of PTHrP Through Ubiquitin-Proteasome System in Hepatocellular Carcinoma. J Cancer (2015) 0.84
Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition. Arch Biochem Biophys (2014) 0.83
Oxidative exposure impairs TGF-β pathway via reduction of type II receptor and SMAD3 in human skin fibroblasts. Age (Dordr) (2014) 0.83
The Smurf ubiquitin ligases regulate tissue separation via antagonistic interactions with ephrinB1. Genes Dev (2013) 0.83
Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1. Nat Commun (2013) 0.83
Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination. Cells (2014) 0.82
Mutations in protein-binding hot-spots on the hub protein Smad3 differentially affect its protein interactions and Smad3-regulated gene expression. PLoS One (2011) 0.82
Searching for cellular partners of hantaviral nonstructural protein NSs: Y2H screening of mouse cDNA library and analysis of cellular interactome. PLoS One (2012) 0.81
Identification of a novel anti-apoptotic E3 ubiquitin ligase that ubiquitinates antagonists of inhibitor of apoptosis proteins SMAC, HtrA2, and ARTS. J Biol Chem (2013) 0.81
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
Smads: transcriptional activators of TGF-beta responses. Cell (1998) 5.33
Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature (1998) 4.13
TGF-beta receptor signaling. Biochim Biophys Acta (1997) 2.99
Microtubule binding to Smads may regulate TGF beta activity. Mol Cell (2000) 2.09
Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol (1997) 2.05
Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. J Immunol (1998) 1.67
On the nature of the "non-saturable" migration of amino acids into Ehrlich cells and into rat jejunum. Bibl Laeger (1966) 1.59
Fractal morphology, imaging and mass spectrometry of single aerosol particles in flight. Nature (2012) 1.56
Cryptotomography: reconstructing 3D Fourier intensities from randomly oriented single-shot diffraction patterns. Phys Rev Lett (2010) 1.55
Roentgenograms in primary care patients with acute low back pain: a cost-effectiveness analysis. Arch Intern Med (1982) 1.53
Consomic rat model systems for physiological genomics. Acta Physiol Scand (2004) 1.50
The use of N-methylation to direct route of mediated transport of amino acids. J Biol Chem (1965) 1.48
A distinct Na+-requiring transport system for alanine, serine, cysteine, and similar amino acids. J Biol Chem (1967) 1.44
Primary structure of hepatocyte nuclear factor/forkhead homologue 4 and characterization of gene expression in the developing respiratory and reproductive epithelium. Proc Natl Acad Sci U S A (1995) 1.33
Single-particle structure determination by correlations of snapshot X-ray diffraction patterns. Nat Commun (2012) 1.30
Differential accumulation of transcripts encoding protein kinase homologs in greening pea seedlings. Proc Natl Acad Sci U S A (1991) 1.28
Transport of diamino acids into the Ehrlich cell. J Biol Chem (1966) 1.24
Temporary alteration of cerebrovascular permeability to plasma protein during drug-induced seizures. Am J Physiol (1972) 1.21
Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese. Nutr Metab Cardiovasc Dis (2009) 1.16
Defensive peripersonal space: the blink reflex evoked by hand stimulation is increased when the hand is near the face. J Neurophysiol (2011) 1.09
Discriminative analysis of brain function at resting-state for attention-deficit/hyperactivity disorder. Med Image Comput Comput Assist Interv (2005) 1.06
The type II transforming growth factor-beta receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem (1997) 1.05
A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. J Biol Chem (2000) 1.03
Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. J Biol Chem (1998) 1.02
Stimulus novelty, and not neural refractoriness, explains the repetition suppression of laser-evoked potentials. J Neurophysiol (2010) 0.98
Pharmacogenomics and translational simulations to bridge indications for an anti-interferon-α receptor antibody. Clin Pharmacol Ther (2013) 0.97
ADP-Ribosyl cyclase in rat vascular smooth muscle cells: properties and regulation. Circ Res (2000) 0.96
A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients. Gene Ther (2008) 0.94
Confocal pattern period in multiple-aperture confocal imaging systems with coherent illumination. Opt Lett (1997) 0.93
The targeting and functions of miRNA-383 are mediated by FMRP during spermatogenesis. Cell Death Dis (2013) 0.93
Femtosecond dark-field imaging with an X-ray free electron laser. Opt Express (2012) 0.93
Elevation of C-reactive protein and interleukin-6 in plasma of patients with aggressive periodontitis. J Periodontal Res (2008) 0.92
CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model. Immunol Lett (2001) 0.92
Regulation of bim in glucocorticoid-mediated osteoblast apoptosis. J Cell Physiol (2008) 0.91
Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients. J Clin Oncol (1996) 0.91
Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus. J Rheumatol (1992) 0.91
Intrarenal serotonin, dopamine, and phosphate handling in remnant kidneys. Kidney Int (2001) 0.89
Partial rescue of the ocular retardation phenotype by genetic modifiers. J Neurobiol (2000) 0.89
Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model. Kidney Int (2007) 0.87
Differential effect of pH upon cyclic-ADP-ribose and nicotinate-adenine dinucleotide phosphate-induced Ca2+ release systems. Biochem J (1998) 0.87
Cytotoxicity of adenoviruses expressing the wild-type p53 gene to esophageal carcinoma cells is linked with the CAR expression level and indirectly with the endogenous p53 status. Cancer Gene Ther (2009) 0.87
Taking into account latency, amplitude, and morphology: improved estimation of single-trial ERPs by wavelet filtering and multiple linear regression. J Neurophysiol (2011) 0.86
Simultaneous rapid high-performance liquid chromatographic determination of phenytoin and its prodrug, fosphenytoin in human plasma and ultrafiltrate. J Chromatogr B Biomed Sci Appl (1997) 0.85
An amino acid transport system of unassigned function in the Ehrlich ascites tumor cell. J Biol Chem (1965) 0.85
Feasibility of willingness-to-pay measurement in chronic arthritis. Med Decis Making (1984) 0.85
Dishabituation of laser-evoked EEG responses: dissecting the effect of certain and uncertain changes in stimulus spatial location. Exp Brain Res (2012) 0.84
Dot-immunobinding assay in the serodiagnosis of human hydatid disease. Am J Trop Med Hyg (1986) 0.84
The primary somatosensory cortex contributes to the latest part of the cortical response elicited by nociceptive somatosensory stimuli in humans. Neuroimage (2013) 0.84
Agonists and phorbol esters desensitize beta-adrenergic receptors by different mechanisms. Mol Pharmacol (1987) 0.84
Letter: Hepatitis-B antibody in polymyalgia rheumatica. Lancet (1976) 0.83
A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma. Cancer Gene Ther (2006) 0.83
The temporal order judgement of tactile and nociceptive stimuli is impaired by crossing the hands over the body midline. Pain (2012) 0.82
Molecular and antigenic characterization of HV114, a hantavirus isolated from a patient with haemorrhagic fever with renal syndrome in China. J Gen Virol (1993) 0.82
Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritis. Br J Pharmacol (2013) 0.81
Health status instruments / utilities. J Rheumatol (1995) 0.81
Estrogen attenuates vascular expression of inflammation associated genes and adhesion of monocytes to endothelial cells. Inflamm Res (2006) 0.81
Modes of uptake of benzylamine by the Ehrlich cell. J Biol Chem (1966) 0.81
Family-based association analysis of S100A8 genetic polymorphisms with aggressive periodontitis. J Periodontal Res (2009) 0.79
Molecular cloning and biochemical characterization of a receptor-like serine/threonine kinase from rice. Plant Mol Biol (1994) 0.79
Physicochemical strategies for inhibition of amyloid fibril formation: an overview of recent advances. Curr Med Chem (2012) 0.79
Chimerism but not neonatal antigen exposure induces transplant tolerance. Scand J Immunol (2012) 0.79
Immunocytochemical demonstration of estrogen receptor beta in human periodontal ligament cells. Arch Oral Biol (2004) 0.78
Discovery of novel non-peptide CCR1 receptor antagonists. J Med Chem (1999) 0.78
Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma. Cancer Gene Ther (2010) 0.78
Application of biotin-avidin system, determination of circulating immune complexes, and evaluation of antibody response in different hydatidosis patients. Am J Trop Med Hyg (1988) 0.78
A patient-administered questionnaire for arthritis assessment. Clin Orthop Relat Res (1978) 0.78
Patient education program to teach energy conservation behaviors to patients with rheumatoid arthritis: a pilot study. Arch Phys Med Rehabil (1987) 0.78
Lack of corneal toxicity of interferon Alpha-2b administered subconjunctivally after sclerectomy. Yan Ke Xue Bao (1997) 0.77
Nucleotide sequence and phylogenetic analysis of the medium (M) genomic RNA segments of three hantaviruses isolated in China. Virus Res (1998) 0.77
Criteria for assessing disease activity in systemic lupus erythematosus. J Rheumatol (1989) 0.77
[Detection of IgG antibody to hepatitis G virus by ELISA]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2000) 0.77
Role of gender on renal interstitial hydrostatic pressure and sodium excretion in rats. Am J Hypertens (2001) 0.77
Population Structures of 'Candidatus Liberibacter asiaticus' in Southern China. Phytopathology (2014) 0.76
Association analysis between the -2518MCP-1(A/G) polymorphism and generalized aggressive periodontitis in a Chinese population. J Periodontal Res (2011) 0.76
The up-regulation of KCC1 gene expression in cervical cancer cells by IGF-II through the ERK1/2MAPK and PI3K/AKT pathways and its significance. Eur J Gynaecol Oncol (2009) 0.75
Seroprevalence of Mycoplasma hyopneumoniae in pigs in subtropical southern China. Trop Anim Health Prod (2010) 0.75
[Determination of roxithromycin in serum by high-performance liquid chromatography with ultraviolet detection]. Hua Xi Yi Ke Da Xue Xue Bao (2001) 0.75
[Human Fab antibodies derived from phage display library neutralize hepatitis A virus in vitro]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2000) 0.75
[Surgery of laryngotracheal stenosis in the adult]. Lin Chuang Er Bi Yan Hou Ke Za Zhi (1998) 0.75
[The efficiency of algae removal from drinking water by ferrate]. Huan Jing Ke Xue (2001) 0.75
3He spin-dependent cross sections and sum rules. Phys Rev Lett (2008) 0.75
Dynamics of the 16O(e, e'p) reaction at high missing energies. Phys Rev Lett (2001) 0.75
[The partial nucleotide sequence of L segment of Hantavirus strain]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2000) 0.75
[Determination of warfarin in plasma by HPLC and an investigation of monitoring patients after cardiac valve replacement]. Hua Xi Yi Ke Da Xue Xue Bao (2001) 0.75
[Study on chromatographic peak identification by means of peak shape analysis]. Se Pu (1999) 0.75
A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients. Cancer Chemother Pharmacol (2001) 0.75
[The metabolism of trehalose and intracellular glycerol in Candida krusei responding to high osmosis]. Sheng Wu Gong Cheng Xue Bao (2001) 0.75
[Study on the immune state of patients with laryngeal carcinoma]. Lin Chuang Er Bi Yan Hou Ke Za Zhi (1997) 0.75
Measurement of the charged pion electromagnetic form factor. Phys Rev Lett (2001) 0.75
[Generation of monoclonal antibody Fab fragments to parathyroid hormone related protein by phage display technology]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2000) 0.75
Precision measurement of the spin-dependent asymmetry in the threshold region of 3He(e, e'). Phys Rev Lett (2001) 0.75
Transverse asymmetry AT' from the quasielastic 3He(e,e') process and the neutron magnetic form factor. Phys Rev Lett (2000) 0.75
Polarization measurements in high-energy deuteron photodisintegration. Phys Rev Lett (2001) 0.75
[Simultaneous determination of norepinephrine and epinephrime in plasma by using high performance liquid chromatograph]. Hua Xi Yi Ke Da Xue Xue Bao (1999) 0.75
Measurement of the generalized forward spin polarizabilities of the neutron. Phys Rev Lett (2004) 0.75
Measurement of the generalized polarizabilities of the proton in virtual Compton scattering at Q2=0.92 and 1.76 GeV2. Phys Rev Lett (2004) 0.75
[Generation of human recombinant antibody Fab fragment to influenza virus from combined antibody library]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2001) 0.75
Effects of removing circulatory tumor necrosis factor by immunoadsorption on experimental endotoxin shock animals. Chin Med J (Engl) (1997) 0.75
[Determination of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human plasma by HPLC]. Hua Xi Yi Ke Da Xue Xue Bao (1999) 0.75